Company Valuation: Streamline Health Solutions, Inc.

Data adjusted to current consolidation scope
Fiscal Period: January 2020 2021 2022 2023 2024 2025
Market Cap 1 32.51 56.42 63.8 120.6 22.17 18.62
Change - 73.52% 13.08% 89.09% -81.62% -16%
Enterprise Value (EV) 1 34.69 56.73 64.06 123.8 29.55 29.56
Change - 63.53% 12.91% 93.25% -76.13% 0.06%
P/E -8.74x 295x -8.97x -9.36x -1.18x -1.81x
PBR 2.04x 3.24x 1.88x 3.39x 1.18x 1.52x
PEG - -3x 0x -0.2x -0x 0x
Capitalization / Revenue 1.57x 4.97x 3.67x 4.85x 0.98x 1.04x
EV / Revenue 1.67x 5x 3.69x 4.97x 1.31x 1.65x
EV / EBITDA 59x -10.7x -9.3x -13.3x -3.85x -4.51x
EV / EBIT -337x -9.71x -8.1x -11.6x -3.33x -3.68x
EV / FCF 73.1x -7.4x 10x -28.8x -20.1x -57.8x
FCF Yield 1.37% -13.5% 10% -3.47% -4.96% -1.73%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -1.889 0.0942 -2.292 -3.46 -4.963 -2.534
Distribution rate - - - - - -
Net sales 1 20.74 11.35 17.38 24.89 22.6 17.9
EBITDA 1 0.588 -5.286 -6.887 -9.286 -7.673 -6.548
EBIT 1 -0.103 -5.841 -7.911 -10.68 -8.871 -8.029
Net income 1 -2.863 0.296 -6.542 -11.38 -18.7 -10.16
Net Debt 1 2.176 0.312 0.256 3.151 7.376 10.94
Reference price 2 16.500 27.750 20.550 32.400 5.850 4.595
Nbr of stocks (in thousands) 1,971 2,033 3,105 3,723 3,790 4,053
Announcement Date 4/22/20 A 4/22/21 A 4/28/22 A 4/27/23 A 4/30/24 A 5/2/25 A
1USD in Million2USD
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 22.07M
13.97x0.41x8.72x2.8% 121B
13.89x1.77x8.82x0.76% 89.14B
23.25x2.59x13.14x1.39% 26.08B
32.57x5.85x24.05x2.13% 22.03B
8.2x1.45x6.63x-.--% 21.76B
14.39x1.4x6.64x4.69% 13.72B
14.05x1.01x5.65x3.5% 12.5B
12.21x1.57x7.59x0.94% 11.35B
Average 16.57x 2.01x 10.16x 2.03% 35.33B
Weighted average by Cap. 15.56x 1.53x 9.78x 1.92%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. STRM Stock
  4. Valuation Streamline Health Solutions, Inc.